Middle East & Africa Impulse Oscillometry Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The Middle East and Africa Impulse Oscillometry Market size is expected to reach US$ 5,408.5 Thousand by 2034 from US$ 3,618.4 Thousand in 2025. The market is estimated to record a CAGR of 4.6% from 2026 to 2034.

Executive Summary and Middle East and Africa Impulse Oscillometry Market Analysis:

The Middle East & Africa impulse oscillometry market is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. The rising prevalence of asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary complications, coupled with a growing emphasis on early and noninvasive diagnosis, is driving the adoption of Impulse oscillometry (IOS) technology in hospitals and diagnostic centers. Technological advancements, such as portable and user-friendly IOS devices, have improved accuracy and patient compliance, boosting demand. Government initiatives and healthcare infrastructure development in countries such as the UAE, Saudi Arabia, and South Africa are supporting the expansion of pulmonary diagnostic services. The growing geriatric population, who are more susceptible to respiratory diseases, contributes to market growth. Increasing investments by key players to introduce advanced IoT systems and strategic partnerships with healthcare providers are accelerating regional market penetration and accessibility.

Middle East & Africa Impulse Oscillometry Market: Strategic Insights

Middle East and Africa Impulse Oscillometry Market Segmentation Analysis:

• By Product, the Middle East and Africa Impulse Oscillometry Market is segmented into Device and Accessories. The Device segment dominated the market in 2025.
• By Device For Product, the Middle East and Africa Impulse Oscillometry Market is segmented into Desktop and Portable. The Desktop segment dominated the market in 2025.
• By Accessories For Product, the Middle East and Africa Impulse Oscillometry Market is segmented into Filters, Nose Clip, Support Arms, and Other Accessories. The Filters segment dominated the market in 2025.
• By Application, the Middle East and Africa Impulse Oscillometry Market is segmented into Asthma, COPD, and Other Applications. The Asthma segment dominated the market in 2025.
• By End User, the Middle East and Africa Impulse Oscillometry Market is segmented into Hospitals and Clinics, Diagnostic Laboratories, and Other End users. The Hospitals and Clinics segment dominated the market in 2025.

Middle East & Africa Impulse Oscillometry Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa Impulse Oscillometry Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Middle East and Africa Impulse Oscillometry Market Outlook

The integration of artificial intelligence (AI) and machine learning (ML) into IOS analysis is transforming lung function assessment by enabling precise, data-driven insights into respiratory mechanics. This trend leverages IOS parameters, such as resistance (R5, R20) and reactance (X5), to build predictive models that classify diseases such as asthma and COPD with high accuracy, surpassing traditional interpretations. A PMC study developed an ML model using IOS profiles to categorize patients into no obstruction, asthma, or COPD, achieving an accuracy of 0.786 with a neural network classifier, where R5-R20 emerged as key features for differentiation. In distinguishing between COPD and asthma, the model achieved 0.854 accuracy. In sarcoidosis, Springer-reported ML classifiers using IOS data assisted in diagnosing respiratory abnormalities, enhancing diagnostic precision. BMJ Open Respiratory Research noted ML methods incorporating IOS for COPD-asthma distinction, with deep learning achieving 0.786 accuracy and identifying X5pred-X5 as crucial for separation. Cureus validated AI in oscillometry for asthma, detecting resistance and reactance accurately. For early COPD detection, BREATH Hannover's AI-combined oscillometry identified small airway dysfunction in 40% of screened individuals, flagging a high-risk group for comorbidities. Per ResearchGate, ML models reached 0.929 accuracy in healthy vs. diseased discrimination using IOS. By processing multidimensional IOS data, AI reduces variability and aids in phenotype identification, promising routine clinical integration for personalized treatment and early intervention in respiratory diseases.

AI integration, exemplified by machine learning models that interpret oscillometric waveforms, has reduced interpretation variability. Research from the American Journal of Respiratory and Critical Care Medicine shows AI-enhanced IOS achieving 95% accuracy in classifying asthma severity. In COPD diagnostics, AI enhances IOS by classifying airway obstruction severity through pattern recognition, differentiating central from peripheral involvement. It aids in selecting optimal interventions such as long-acting muscarinic antagonists. Researchers are exploring AI-driven predictive analytics in IOS for post-surgical lung function recovery, where algorithms forecast complications based on preoperative impedance profiles. This integration facilitates the aggregation of big data from multiple iOS devices, enabling ML to refine normative values across demographics and improve diagnostic equity. In clinical trials for new respiratory drugs, AI analyzes IOS endpoints to evaluate efficacy faster, streamlining development. This trend empowers IOS with smarter, faster insights, reducing diagnostic errors and personalizing care, while fostering wearable sensors that feed data into ML ecosystems for continuous monitoring, marking a new era in respiratory diagnostics.

Middle East and Africa Impulse Oscillometry Market Country Insights

By country, the Middle East and Africa Impulse Oscillometry Market is segmented into Saudi Arabia, South Africa, the United Arab Emirates, and the Rest of Middle East and Africa. South Africa held the largest share in 2025.

The market in South Africa is expanding, driven by the high and persistent burden of chronic respiratory diseases, notably COPD and asthma, amid widespread risk factors such as tobacco use, biomass fuel exposure, and previous tuberculosis. Oscillometry offers distinct clinical advantages as an effort-independent, sensitive method for evaluating small airways and peripheral lung function. The country remains among those in Africa with the highest rates of childhood asthma. According to the article "Rising asthma rates in sub-Saharan Africa linked to urbanization and lack of care," published in October 2024, data from the International Study of Asthma and Allergies in Childhood (ISAAC) show that two-thirds of adolescents experienced severe asthma symptoms, while 80% had never been diagnosed. Meanwhile, the Burden of Obstructive Lung Disease (BOLD) study, which assessed global COPD prevalence, reported that 19% of South Africans are affected. The burden of COPD continues to grow due to persistent smoking and an aging population.

Middle East and Africa Impulse Oscillometry Market Company Profiles

Some of the key players operating in the market include COSMED Srl, Chest MI Inc, Morgan Scientific Inc, THORASYS Thoracic Medical Systems Inc., Jaeger Medical GmbH, GANSHORN Medizin Electronic GmbH, Vitalograph Ltd, Lothar Medical GmbH, Cognita Labs, LLC, and RESTECH srl.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East and Africa Impulse Oscillometry Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise